![Erick Gamelin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erick Gamelin
Corporate Officer/Principal bei
ACRIVON THERAPEUTICS, INC.
Vermögen: 84 787 $ am 31.05.2026
Profil
Erick Gamelin is currently the Chief Development Officer at Acrivon Therapeutics, Inc. He previously held positions as the Vice President-Oncology at Dynavax Technologies Corp., Vice President at MacroGenics, Inc., and Chief Medical Officer at Step Pharma SAS.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.05.2026 | 52.992 ( 0,12 % ) | 84 787 $ | 31.05.2026 |
Aktive Positionen von Erick Gamelin
| Unternehmen | Position | Beginn |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Corporate Officer/Principal | 03.01.2024 |
Ehemalige bekannte Positionen von Erick Gamelin
| Unternehmen | Position | Ende |
|---|---|---|
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01.10.2019 |
| MACROGENICS, INC. | Corporate Officer/Principal | 01.03.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
7
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
